ESPR FY 2016 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ESPREsperion Therapeutics, Inc.

$519M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$252,000

Operating Income

-$76M

Net Income

-$75M

EPS (Diluted)

$-3.33

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$245M

Total Liabilities

$17M

Stockholders' Equity

$229M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$252,000	-$236,000	-6.8%
Operating Income	-$76M	-$50M	-52.2%
Net Income	-$75M	-$50M	-50.6%